Results 181 to 190 of about 8,134 (194)

Predictive parameter of tolvaptan effectiveness in cirrhotic ascites

Hepatology Research, 2017
Hideto Kawaratani, Hiroshi Fukui, Kei Moriya   +2 more
exaly  

Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion

Hypertension Research, 2018
Yoshihiro Seo, Tomoko Ishizu
exaly  

Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist, in healthy subjects

European Journal of Clinical Pharmacology, 2011
Suresh Mallikaarjun
exaly  

Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan

Journal of Gastroenterology, 2015
Hidetsugu Tsubouchi
exaly  

Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease

Drugs, 2015
exaly  

Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis

Internal Medicine, 2016
Takuya Iwamoto, Tsuyoshi Ishikawa, Taro Takami   +2 more
exaly  

Tolvaptan, an Orally Active Vasopressin V2‐Receptor Antagonist—Pharmacology and Clinical Trials

Cardiovascular Drug Reviews, 2007
exaly  

Phase III Clinical Pharmacology Study of Tolvaptan

Cardiovascular Drugs and Therapy, 2011
exaly  

Tolvaptan

Reactions Weekly, 2013
openaire   +1 more source

Tolvaptan

Reactions Weekly, 2015
openaire   +2 more sources